 - Patient has been off all anti-viral medications, including any unapproved or experimental treatment for HIV and antiretrovirals, for at least 4 weeks prior to Study Day-1 baseline. The patient may initiate this 4 week period after screening, if, in the judgment of the principal investigator, the patient qualifies for the study. 